TD Asset Management
ACAD icon

TD Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$971K Buy
+45,000
New +$971K ﹤0.01% 1065
2024
Q3
Sell
-23,296
Closed -$379K 1386
2024
Q2
$379K Sell
23,296
-82,800
-78% -$1.35M ﹤0.01% 1305
2024
Q1
$1.96M Sell
106,096
-100,400
-49% -$1.86M ﹤0.01% 1029
2023
Q4
$6.47M Sell
206,496
-19,200
-9% -$601K 0.01% 697
2023
Q3
$4.7M Buy
225,696
+51,273
+29% +$1.07M 0.01% 745
2023
Q2
$4.18M Buy
174,423
+57,502
+49% +$1.38M ﹤0.01% 786
2023
Q1
$2.2M Buy
116,921
+13,600
+13% +$256K ﹤0.01% 954
2022
Q4
$1.64M Sell
103,321
-23,339
-18% -$372K ﹤0.01% 1042
2022
Q3
$2.04M Buy
126,660
+15,300
+14% +$247K ﹤0.01% 991
2022
Q2
$1.57M Buy
111,360
+15,400
+16% +$217K ﹤0.01% 1075
2022
Q1
$2.32M Sell
95,960
-40,882
-30% -$990K ﹤0.01% 1043
2021
Q4
$3.19M Buy
136,842
+11,791
+9% +$275K ﹤0.01% 1006
2021
Q3
$2.08M Sell
125,051
-12,700
-9% -$211K ﹤0.01% 1073
2021
Q2
$2.98M Sell
137,751
-1,766
-1% -$38.2K ﹤0.01% 964
2021
Q1
$3.6M Sell
139,517
-43,656
-24% -$1.13M ﹤0.01% 924
2020
Q4
$9.79M Sell
183,173
-59,200
-24% -$3.16M 0.01% 597
2020
Q3
$10M Sell
242,373
-13,100
-5% -$540K 0.01% 547
2020
Q2
$12.4M Buy
255,473
+10,297
+4% +$499K 0.02% 468
2020
Q1
$10.4M Sell
245,176
-37,943
-13% -$1.6M 0.02% 463
2019
Q4
$12.1M Buy
283,119
+75,214
+36% +$3.22M 0.02% 502
2019
Q3
$7.48M Buy
207,905
+42,456
+26% +$1.53M 0.01% 592
2019
Q2
$4.42M Buy
165,449
+5,700
+4% +$152K 0.01% 711
2019
Q1
$4.29M Buy
159,749
+12,500
+8% +$336K 0.01% 732
2018
Q4
$2.38M Buy
147,249
+39,649
+37% +$641K ﹤0.01% 871
2018
Q3
$2.23M Buy
+107,600
New +$2.23M ﹤0.01% 964
2017
Q4
Sell
-32,761
Closed -$1.23M 1330
2017
Q3
$1.23M Sell
32,761
-29,500
-47% -$1.11M ﹤0.01% 984
2017
Q2
$1.74M Sell
62,261
-23,400
-27% -$652K ﹤0.01% 909
2017
Q1
$2.95M Sell
85,661
-28,726
-25% -$988K ﹤0.01% 810
2016
Q4
$3.3M Sell
114,387
-27,300
-19% -$787K 0.01% 763
2016
Q3
$4.51M Sell
141,687
-9,313
-6% -$296K 0.01% 725
2016
Q2
$4.9M Sell
151,000
-26,400
-15% -$857K 0.01% 681
2016
Q1
$4.96M Buy
177,400
+46,900
+36% +$1.31M 0.01% 677
2015
Q4
$4.65M Sell
130,500
-4,400
-3% -$157K 0.01% 679
2015
Q3
$4.46M Buy
134,900
+6,000
+5% +$198K 0.01% 661
2015
Q2
$5.4M Sell
128,900
-2,900
-2% -$121K 0.01% 645
2015
Q1
$4.3M Buy
131,800
+13,700
+12% +$446K 0.01% 699
2014
Q4
$3.75M Buy
118,100
+3,000
+3% +$95.3K 0.01% 735
2014
Q3
$2.85M Buy
115,100
+8,000
+7% +$198K ﹤0.01% 767
2014
Q2
$2.42M Buy
107,100
+65,900
+160% +$1.49M ﹤0.01% 803
2014
Q1
$1M Buy
41,200
+3,300
+9% +$80.3K ﹤0.01% 905
2013
Q4
$947K Buy
37,900
+5,200
+16% +$130K ﹤0.01% 890
2013
Q3
$898K Buy
32,700
+3,800
+13% +$104K ﹤0.01% 885
2013
Q2
$525K Buy
+28,900
New +$525K ﹤0.01% 925